Asset Comparison and Correlation
|BristolMyers Squibb Company vs Biocon Limited|
Considering 30-days investment horizon, BristolMyers Squibb Company is expected to generate 1.36 times more return on investment than Biocon. However, BristolMyers is 1.36 times more volatile than Biocon Limited. It trades about 0.17 of its potential returns per unit of risk. Biocon Limited is currently generating about 0.01 per unit of risk. If you would invest 4,115 in BristolMyers Squibb Company on April 18, 2013 and sell it today you would earn a total of 215.00 from holding BristolMyers Squibb Company or generate 5.22% return on investment over 30 days.
91% of all equities and portfolios perform better than BristolMyers Squibb Company. Compared with the overall equity markets, risk-adjusted returns on investments in BristolMyers Squibb Company are ranked lower than 9 (%) of all global equities and portfolios over the last 30 days.
Match ups for BristolMyers
Over the last 30 days Biocon Limited has generated negative risk-adjusted returns adding no value to investors with long positions.
Match ups for Biocon